07:15 AM EDT, 08/13/2025 (MT Newswires) -- (Updates with attribution to Eli Lilly ( LLY ) throughout and additional details in second paragraph)

Eli Lilly ( LLY ) said Wednesday that its obesity and type 2 diabetes drug Mounjaro in its KwikPen form is now available across India in all doses.

Mounjaro Kwikpen, approved by India's Central Drugs Standard Control Organisation in June, is a pre-filled pen containing four fixed doses intended for use by a single patient, and which is to be administered once weekly, the company said.

Eli Lilly ( LLY ) said that the product will be available across six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.

Mounjaro Kwikpen will be priced at 14,000 Indian rupees ($160.14) for its 2.5 mg dose, with the price reaching 27,500 rupees for its 15 mg pen, the company added.